Amgen Stock Surges to All-Time High

Amgen's stock has reached an all-time high of $398.65 and is currently trading at $403.13, giving the biotechnology giant a market capitalization of $210.5 billion.

This milestone comes after a strong year for Amgen, with its stock price increasing by 37.01% over the past 12 months.

The company's recent second-quarter financial results exceeded Wall Street expectations, with adjusted earnings of $6.29 per share and revenue reaching $10.1 billion, surpassing projected figures.

Amgen has raised its financial guidance for the year following these strong results, reflecting investor confidence in the company's performance and future prospects.